Latest News and Press Releases

DEESIDE, Flintshire, U.K., Dec. 13, 2004 (PRIMEZONE) -- Provalis plc (LSE:PRO) (Nasdaq:PVLS), the Medical Diagnostics and Pharmaceuticals Group, today announces that it has signed an option agreement...

DEESIDE, FLINTSHIRE, U.K., Dec. 3, 2004 (PRIMEZONE) -- Provalis plc (LSE:PRO) (Nasdaq:PVLS), the Medical Diagnostics and Pharmaceuticals Group, is pleased to announce that its Medical Diagnostics...

DEESIDE, Flintshire, UK, Sept. 17, 2004 (PRIMEZONE) -- The following meetings will be held on the day of the results at Buchanan Communications 107 Cheapside EC2V. Analysists at 10:15 am Press at...

DEESIDE, Flintshire, U.K., Sept. 17, 2004 (PRIMEZONE) -- Provalis PLC: The following meetings will be held on the day of the results at Buchanan Communications 107 Cheapside EC2V. Analysists at...

DEESIDE, Flintshire, U.K., Sept. 14, 2004 (PRIMEZONE) -- On behalf of our client Provalis plc, we would like to notify investors that running simultaneously to the briefing at 10.15 am there will be...

Deeside, Flintshire, UK, Sept. 6, 2004 (PRIMEZONE) PROVALIS PLC NOTIFICATION OF PRELIMINARY RESULTS for the year ended 30 June...

DEESIDE, Flintshire, U.K., Aug. 19, 2004 (PRIMEZONE) -- Provalis plc (LSE:PRO) (Nasdaq:PVLS) is delighted to announce that its Medical Diagnostics Division, has today received 510K regulatory...

DEESIDE, Flintshire, U.K., July 11, 2004 (PRIMEZONE) -- Provalis plc (LSE:PRO) (Nasdaq:PVLS), the Medical Diagnostics and Pharmaceuticals Group, is pleased to announce that its unaudited results for...

DEESIDE, Flintshire, U.K., July 1, 2004 (PRIMEZONE) -- Provalis plc (LSE:PRO) (Nasdaq:PVLS), the Medical Diagnostics and Pharmaceuticals Group, today announces that it has signed an option agreement...

DEESIDE, U.K., June 17, 2004 (PRIMEZONE) -- Provalis plc (LSE:PRO) (Nasdaq:PVLS), the Medical Diagnostics and Pharmaceuticals Group, is pleased to announce that, on schedule, it has filed the USA...